55.0
Novo Nordisk A/S Sponsored ADR
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions DKK
FY21:
FY22:
78.9
FY23:
109
FY24:
121
FY25:
119
Change from FY21 to FY25
billions DKK
FY21:
−31.6
FY22:
−24.9
FY23:
−43.9
FY24:
−129
FY25:
−79.2
Change from FY21 to FY25
billions DKK
FY21:
−25.5
FY22:
−51.8
FY23:
−63.2
FY24:
8.74
FY25:
−28.4
billions DKK
FY21:
−2.10
FY22:
2.17
FY23:
1.86
FY24:
0.81
FY25:
11.5
(positive)
Change from FY21 to FY25
billions DKK
FY21:
48.7
FY22:
66.7
FY23:
83.1
FY24:
73.8
FY25:
59.0
All amounts in billions DKK